{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:47:34Z","timestamp":1794980854642,"version":"4.9.1"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010881","name":"Suzhou City Science and Technology Bureau","doi-asserted-by":"publisher","award":["SZKJXM202214"],"award-info":[{"award-number":["SZKJXM202214"]}],"id":[{"id":"10.13039\/501100010881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018552","name":"Science and Technology Plan Project of Taizhou","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010950","name":"Department of Science and Technology of Henan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["222102310729"],"award-info":[{"award-number":["222102310729"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["242102311181"],"award-info":[{"award-number":["242102311181"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ijbiomac.2024.134899","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T07:07:15Z","timestamp":1724483235000},"page":"134899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"P4","title":["Application of chitosan as nano carrier in the treatment of inflammatory bowel disease"],"prefix":"10.1016","volume":"278","author":[{"given":"Xiaoming","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunrui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijbiomac.2024.134899_bb0005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.134899_bb0010","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","article-title":"The global burden of IBD: from 2015 to 2025","volume":"12","author":"Kaplan","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.134899_bb0015","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s40258-016-0272-z","article-title":"Inflammatory bowel diseases (Crohn s disease and ulcerative colitis): cost of treatment in Serbia and the implications","volume":"15","author":"Kostic","year":"2017","journal-title":"Appl. Health Econ. Health Policy"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.134899_bb0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","article-title":"Immunopathogenesis of IBD: current state of the art","volume":"13","author":"de Souza","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.134899_bb0025","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1053\/j.gastro.2010.01.058","article-title":"Inflammation and colon cancer","volume":"138","author":"Terzic","year":"2010","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.134899_bb0030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000465522","article-title":"Epidemiology of inflammatory bowel disease in India: the great shift east","volume":"2","author":"Kedia","year":"2017","journal-title":"Inflamm. Intest. Dis."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.134899_bb0035","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.crohns.2013.01.010","article-title":"The burden of inflammatory bowel disease in Europe","volume":"7","author":"Burisch","year":"2013","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0040","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2147\/JIR.S165330","article-title":"Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives","volume":"11","author":"Rawla","year":"2018","journal-title":"J. Inflamm. Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.134899_bb0045","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ejps.2013.04.031","article-title":"Overcoming therapeutic obstacles in inflammatory bowel diseases: a comprehensive review on novel drug delivery strategies","volume":"49","author":"Talaei","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.134899_bb0050","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/ibd\/izy123","article-title":"Nanoparticle-based oral drug delivery systems targeting the colon for treatment of ulcerative colitis","volume":"24","author":"Zhang","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.addr.2013.10.001","article-title":"Drug delivery strategies in the therapy of inflammatory bowel disease","volume":"71","author":"Lautenschlager","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0060","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.addr.2018.06.021","article-title":"Bioresponsive drug delivery systems in intestinal inflammation: state-of-the-art and future perspectives","volume":"146","author":"Kotla","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0065","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2147\/JIR.S304101","article-title":"Recent progress in the diagnosis and precise nanocarrier-mediated therapy of inflammatory bowel disease","volume":"14","author":"Wang","year":"2021","journal-title":"J. Inflamm. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.134899_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijpharm.2012.07.017","article-title":"Drug delivery to inflamed colon by nanoparticles: comparison of different strategies","volume":"440","author":"Coco","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.134899_bb0075","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1517\/17425247.2016.1114604","article-title":"Size-dependent nanoparticulate drug delivery in inflammatory bowel diseases","volume":"13","author":"Youshia","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.134899_bb0080","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1038\/s41467-018-04605-x","article-title":"Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap","volume":"9","author":"Song","year":"2018","journal-title":"Nat. Commun."},{"issue":"22","key":"10.1016\/j.ijbiomac.2024.134899_bb0085","doi-asserted-by":"crossref","first-page":"10106","DOI":"10.7150\/thno.48448","article-title":"Amelioration of ulcerative colitis via inflammatory regulation by macrophage-biomimetic nanomedicine","volume":"10","author":"Sun","year":"2020","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.134899_bb0090","doi-asserted-by":"crossref","first-page":"6887","DOI":"10.1021\/acsnano.0c01018","article-title":"Nanoparticles derived from the natural antioxidant rosmarinic acid ameliorate acute inflammatory bowel disease","volume":"14","author":"Chung","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2017.06.003","article-title":"Nanoformulations for combination or cascade anticancer therapy","volume":"115","author":"Miao","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.134899_bb0100","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1021\/acs.biomac.8b00440","article-title":"Enzyme-responsive charge-reversal polymer-mediated effective gene therapy for intraperitoneal tumors","volume":"19","author":"Qiu","year":"2018","journal-title":"Biomacromolecules"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.134899_bb0105","first-page":"1751","article-title":"Vasodilator hydralazine promotes nanoparticle penetration in advanced desmoplastic tumors","volume":"13","author":"Chen","year":"2019","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.134899_bb0110","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.3390\/pharmaceutics13101686","article-title":"Chitosan nanoparticles at the biological interface: implications for drug delivery","volume":"13","author":"Aibani","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2018.12.074","article-title":"Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease","volume":"558","author":"Zeeshan","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"Pt A","key":"10.1016\/j.ijbiomac.2024.134899_bb0120","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ijbiomac.2020.09.214","article-title":"Natural proteins and polysaccharides in the development of micro\/nano delivery systems for the treatment of inflammatory bowel disease","volume":"165","author":"Shah","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.134899_bb0125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0168-3659(03)00126-3","article-title":"Chitosan-based gastrointestinal delivery systems","volume":"89","author":"Hejazi","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0130","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.carbpol.2018.12.011","article-title":"Biomedical applications of chitosan electrospun nanofibers as a green polymer - review","volume":"207","author":"Kalantari","year":"2019","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0135","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijbiomac.2017.12.078","article-title":"A review on chitosan and its nanocomposites in drug delivery","volume":"109","author":"Ali","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0140","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ijbiomac.2020.03.148","article-title":"Advances and applications of chitosan-based nanomaterials as oral delivery carriers: a review","volume":"154","author":"Lang","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.134899_bb0145","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.drudis.2015.03.002","article-title":"The design of pH-sensitive chitosan-based formulations for gastrointestinal delivery","volume":"20","author":"Du","year":"2015","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.134899_bb0150","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3390\/ijms21020487","article-title":"Chitosan derivatives and their application in biomedicine","volume":"21","author":"Wang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"26","key":"10.1016\/j.ijbiomac.2024.134899_bb0155","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1016\/j.biomaterials.2011.03.056","article-title":"Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening","volume":"32","author":"Yeh","year":"2011","journal-title":"Biomaterials"},{"issue":"33","key":"10.1016\/j.ijbiomac.2024.134899_bb0160","doi-asserted-by":"crossref","first-page":"8712","DOI":"10.1016\/j.biomaterials.2011.07.086","article-title":"Effects of chitosan-nanoparticle-mediated tight junction opening on the oral absorption of endotoxins","volume":"32","author":"Sonaje","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0165","doi-asserted-by":"crossref","first-page":"2645465","DOI":"10.1155\/2018\/2645465","article-title":"Tight junction in the intestinal epithelium: its association with diseases and regulation by phytochemicals","volume":"2018","author":"Lee","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0170","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.3389\/fphys.2018.01942","article-title":"Tight junction proteins and signaling pathways in cancer and inflammation: a functional crosstalk","volume":"9","author":"Bhat","year":"2018","journal-title":"Front. Physiol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.134899_bb0175","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrm.2016.80","article-title":"Tight junctions: from simple barriers to multifunctional molecular gates","volume":"17","author":"Zihni","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0180","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.carbpol.2016.10.021","article-title":"Mechanism of surface charge triggered intestinal epithelial tight junction opening upon chitosan nanoparticles for insulin oral delivery","volume":"157","author":"Wang","year":"2017","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.134899_bb0185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2009.09.004","article-title":"Biodegradation, biodistribution and toxicity of chitosan","volume":"62","author":"Kean","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.134899_bb0190","doi-asserted-by":"crossref","first-page":"195","DOI":"10.15171\/apb.2019.023","article-title":"Current advances in chitosan nanoparticles based drug delivery and targeting","volume":"9","author":"Garg","year":"2019","journal-title":"Adv. Pharm. Bull."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.134899_bb0195","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ijbiomac.2011.12.034","article-title":"Design and characterization of antitumor drug paclitaxel-loaded chitosan nanoparticles by W\/O emulsions","volume":"50","author":"Xu","year":"2012","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.134899_bb0200","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3390\/ijms12010266","article-title":"Effects of the molecular weight and the degree of deacetylation of chitosan oligosaccharides on antitumor activity","volume":"12","author":"Park","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116420","article-title":"Ionically crosslinked chitosan\/poly(acrylic acid) hydrogels with high strength, toughness and antifreezing capability","volume":"242","author":"Cao","year":"2020","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.134899_bb0210","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1039\/C8BM00657A","article-title":"Layer-by-layer deposition of chitosan nanoparticles as drug-release coatings for PCL nanofibers","volume":"7","author":"Sydow","year":"2018","journal-title":"Biomater. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.134899_bb0215","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/jps.22763","article-title":"Enhanced immune response against pertussis toxoid by IgA-loaded chitosan-dextran sulfate nanoparticles","volume":"101","author":"Sharma","year":"2012","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.134899_bb0220","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3390\/polym10030235","article-title":"Chitosan based self-assembled nanoparticles in drug delivery","volume":"10","author":"Quinones","year":"2018","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0225","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.ijbiomac.2020.11.072","article-title":"Chitosan based-nanoparticles and nanocapsules: overview, physicochemical features, applications of a nanofibrous scaffold, and bioprinting","volume":"167","author":"Shoueir","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.134899_bb0230","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.3390\/molecules23102661","article-title":"Chitosan-based nanomaterials for drug delivery","volume":"23","author":"Li","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2020.102227","article-title":"Microemulsions as nano-reactors for the solubilization, separation, purification and encapsulation of bioactive compounds","volume":"283","author":"Jalali-Jivan","year":"2020","journal-title":"Adv. Colloid Interface Sci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.134899_bb0240","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1016\/j.biortech.2007.08.017","article-title":"Adsorption of bovin serum albumin (BSA) onto the magnetic chitosan nanoparticles prepared by a microemulsion system","volume":"99","author":"Wang","year":"2008","journal-title":"Bioresour. Technol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.134899_bb0245","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.3390\/ijms19123833","article-title":"Stearoyl-chitosan coated nanoparticles obtained by microemulsion cold dilution technique","volume":"19","author":"Chirio","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0250","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2147\/DDDT.S99651","article-title":"Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery","volume":"10","author":"Ahmed","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.117110","article-title":"Spray-dried alginate-coated Pickering emulsion stabilized by chitosan for improved oxidative stability and in vitro release profile","volume":"251","author":"Surjit Singh","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0260","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2019.02.044","article-title":"Spray freeze drying: emerging applications in drug delivery","volume":"300","author":"Vishali","year":"2019","journal-title":"J. Control Release, Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.134899_bb0265","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ijbiomac.2010.10.005","article-title":"Synthesis and in vitro evaluation of carboxymethyl starch-chitosan nanoparticles as drug delivery system to the colon","volume":"48","author":"Saboktakin","year":"2011","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0270","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/628157","article-title":"Intestinal permeability in inflammatory bowel disease: pathogenesis, clinical evaluation, and therapy of leaky gut","volume":"2015","author":"Michielan","year":"2015","journal-title":"Mediat. Inflamm."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.134899_bb0275","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/1061186X.2011.654121","article-title":"Chitosan nanoparticles: a survey of preparation methods","volume":"20","author":"Grenha","year":"2012","journal-title":"J. Drug Target."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.134899_bb0280","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.nano.2015.02.018","article-title":"Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue","volume":"11","author":"Hua","year":"2015","journal-title":"Nanomedicine"},{"issue":"37","key":"10.1016\/j.ijbiomac.2024.134899_bb0285","doi-asserted-by":"crossref","first-page":"20809","DOI":"10.1039\/C8RA01898G","article-title":"Biodistribution and targeting potential assessment of mucoadhesive chitosan nanoparticles designed for ulcerative colitis via scintigraphy","volume":"8","author":"Raj","year":"2018","journal-title":"RSC Adv."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.134899_bb0290","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0955-2863(01)00208-X","article-title":"The effect of chitosan and other polycations on tight junction permeability in the human intestinal Caco-2 cell line(1)","volume":"13","author":"Ranaldi","year":"2002","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0295","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijpharm.2012.04.012","article-title":"Absorption-promoting effects of chitosan in airway and intestinal cell lines: a comparative study","volume":"430","author":"Vllasaliu","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.134899_bb0300","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.xphs.2020.10.002","article-title":"Galactosylated chitosan coated liposomes of Ledipasvir for liver targeting: chemical synthesis, statistical optimization, in-vitro and in-vivo evaluation","volume":"110","author":"Fatouh","year":"2021","journal-title":"J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.134899_bb0305","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ymthe.2016.11.020","article-title":"Orally targeted delivery of tripeptide KPV via hyaluronic acid-functionalized nanoparticles efficiently alleviates ulcerative colitis","volume":"25","author":"Xiao","year":"2017","journal-title":"Mol. Ther."},{"issue":"24","key":"10.1016\/j.ijbiomac.2024.134899_bb0310","first-page":"00713","article-title":"MMX mesalamine in ulcerative colitis: major advantages towards classical mesalamine formulations","volume":"S1590-8658","author":"D\u2019Amico","year":"2024","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0315","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.carbpol.2019.02.049","article-title":"Improvement of the therapeutic treatment of inflammatory bowel diseases following rectal administration of mesalazine-loaded chitosan microparticles vs Asamax","volume":"212","author":"Palma","year":"2019","journal-title":"Carbohydr. Polym."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.134899_bb0320","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/apt.12464","article-title":"Therapeutics, systematic review: the efficacy of herbal therapy in inflammatory bowel disease","volume":"38","author":"Ng","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.134899_bb0325","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jpba.2007.03.022","article-title":"Determination of berberine in human plasma by liquid chromatography-electrospray ionization-mass spectrometry","volume":"44","author":"Hua","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0330","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijpharm.2016.10.002","article-title":"Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis","volume":"515","author":"Wang","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0335","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.foodres.2015.05.058","article-title":"Curcumin encapsulated in the complex of lysozyme\/carboxymethylcellulose and implications for the antioxidant activity of curcumin","volume":"75","author":"Li","year":"2015","journal-title":"Food Res. Int."},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0340","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.ijbiomac.2020.11.117","article-title":"Carboxymethyl chitosan microspheres loaded hyaluronic acid\/gelatin hydrogels for controlled drug delivery and the treatment of inflammatory bowel disease","volume":"167","author":"Zhang","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.134899_bb0345","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1021\/acs.molpharmaceut.0c01245","article-title":"Smart responsive quercetin-conjugated glycol chitosan prodrug micelles for treatment of inflammatory bowel diseases","volume":"18","author":"Shen","year":"2021","journal-title":"Mol. Pharm."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.134899_bb0350","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrd2805","article-title":"Averting inflammation by targeting the cytokine environment","volume":"9","author":"Kopf","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.134899_bb0355","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2036.2008.03734.x","article-title":"The impact of infliximab infusion reactions on long-term outcomes in patients with Crohn\u2019s disease","volume":"28","author":"Moss","year":"2008","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118556","article-title":"Oral delivery of infliximab using nano-in-microparticles for the treatment of inflammatory bowel disease","volume":"273","author":"Li","year":"2021","journal-title":"Carbohydr. Polym."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.134899_bb0365","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/gut.2009.184556","article-title":"Targeting delivery of anti-TNFalpha oligonucleotide into activated colonic macrophages protects against experimental colitis","volume":"59","author":"Zuo","year":"2010","journal-title":"Gut"},{"issue":"30","key":"10.1016\/j.ijbiomac.2024.134899_bb0370","doi-asserted-by":"crossref","first-page":"7565","DOI":"10.1016\/j.biomaterials.2012.06.104","article-title":"Biomedical applications of amino acid-modified chitosans: a review","volume":"33","author":"Casettari","year":"2012","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.134899_bb0375","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0168-3659(00)00361-8","article-title":"Chitosan-DNA nanopaticles as gene carriers synthesis, characterization and trans fection efficiency","volume":"70","author":"Hai-Quan Mao","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0380","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3389\/fimmu.2012.00322","article-title":"TIR8\/SIGIRR is an interleukin-1 receptor\/toll like receptor family member with regulatory functions in inflammation and immunity","volume":"3","author":"Riva","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0385","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.imlet.2017.01.015","article-title":"Ectopic expression of SIGIRR in the colon ameliorates colitis in mice by downregulating TLR4\/NF-kappaB overactivation","volume":"183","author":"Liu","year":"2017","journal-title":"Immunol. Lett."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.134899_bb0390","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/ecco-jcc\/jjac019","article-title":"Tollip orchestrates macrophage polarization to alleviate intestinal mucosal inflammation","volume":"16","author":"Liu","year":"2022","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0395","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ijpharm.2019.02.016","article-title":"Novel chitosan based nanoparticles as gene delivery systems to cancerous and noncancerous cells","volume":"560","author":"Rahmani","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0400","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jconrel.2016.08.017","article-title":"RNAi-mediated silencing of TNF-alpha converting enzyme to down-regulate soluble TNF-alpha production for treatment of acute and chronic colitis","volume":"239","author":"Song","year":"2016","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.134899_bb0405","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s13346-013-0156-9","article-title":"The application of RNAi-based treatments for inflammatory bowel disease","volume":"4","author":"Olesen","year":"2014","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0410","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jcis.2016.11.088","article-title":"Effects of tripolyphosphate on cellular uptake and RNA interference efficiency of chitosan-based nanoparticles in raw 264.7 macrophages","volume":"490","author":"Xiao","year":"2017","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0415","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejps.2018.10.009","article-title":"Orally targeted galactosylated chitosan poly(lactic-co-glycolic acid) nanoparticles loaded with TNF-a siRNA provide a novel strategy for the experimental treatment of ulcerative colitis","volume":"125","author":"Huang","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0420","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jconrel.2014.04.046","article-title":"Fab\u2019-bearing siRNA TNFalpha-loaded nanoparticles targeted to colonic macrophages offer an effective therapy for experimental colitis","volume":"186","author":"Laroui","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0425","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jconrel.2018.08.021","article-title":"TNFalpha gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis","volume":"287","author":"Xiao","year":"2018","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.134899_bb0430","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1053\/j.gastro.2014.01.056","article-title":"Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice","volume":"146","author":"Xiao","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0435","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.colsurfb.2016.03.035","article-title":"Urocanic acid-modified chitosan nanoparticles can confer anti-inflammatory effect by delivering CD98 siRNA to macrophages","volume":"143","author":"Xiao","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.134899_bb0440","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nantod.2014.04.008","article-title":"Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects","volume":"9","author":"Barua","year":"2014","journal-title":"Nano Today"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.134899_bb0445","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1021\/acs.analchem.8b05120","article-title":"Isotope labeling strategies for acylcarnitines profile in biological samples by liquid chromatography-mass spectrometry","volume":"91","author":"Li","year":"2019","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0450","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fphar.2014.00138","article-title":"Orally administered liposomal formulations for colon targeted drug delivery","volume":"5","author":"Hua","year":"2014","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.134899_bb0455","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.it.2004.12.001","article-title":"The mannose receptor: linking homeostasis and immunity through sugar recognition","volume":"26","author":"Taylor","year":"2005","journal-title":"Trends Immunol."},{"issue":"sup2","key":"10.1016\/j.ijbiomac.2024.134899_bb0460","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/21691401.2018.1463232","article-title":"Surface engineered lipid nanoparticle-mediated site-specific drug delivery system for the treatment of inflammatory bowel disease","volume":"46","author":"Sinhmar","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.134899_bb0465","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.4049\/jimmunol.165.10.5428","article-title":"Dermal microvascular endothelial cells express the 180-kDa macrophage mannose receptor in situ and in vitro","volume":"165","author":"Groger","year":"2000","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.134899_bb0470","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1097\/MIB.0000000000000824","article-title":"Role of monocytes and intestinal macrophages in Crohn\u2019s disease and ulcerative colitis","volume":"22","author":"Gren","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0475","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13020-019-0224-2","article-title":"Chinese herb pair Paeoniae Radix Alba and Atractylodis Macrocephalae Rhizoma suppresses LPS-induced inflammatory response through inhibiting MAPK and NF-kappaB pathway","volume":"14","author":"Zhou","year":"2019","journal-title":"Chin. Med."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.134899_bb0480","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/ecco-jcc\/jjy181","article-title":"A molecular targeted immunotherapeutic strategy for ulcerative colitis via dual-targeting nanoparticles delivering miR-146b to intestinal macrophages","volume":"13","author":"Deng","year":"2019","journal-title":"J. Crohns Colitis"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.134899_bb0485","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jconrel.2013.02.004","article-title":"Optimization of cell receptor-specific targeting through multivalent surface decoration of polymeric nanocarriers","volume":"168","author":"D\u2019Addio","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0490","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.biomaterials.2015.02.044","article-title":"Effects of mannose density on in vitro and in vivo cellular uptake and RNAi efficiency of polymeric nanoparticles","volume":"52","author":"Chu","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0495","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s004410051062","article-title":"Distribution of murine mannose receptor expression from early embryogenesis through to adulthood","volume":"292","author":"D.M. Takahashi","year":"1998","journal-title":"Cell Tissue Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.134899_bb0500","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jb\/mvm017","article-title":"Properties of blocking and non-blocking monoclonal antibodies specific for human macrophage galactose-type C-type lectin (MGL\/ClecSF10A\/CD301)","volume":"141","author":"Sano","year":"2007","journal-title":"J. Biochem."},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0505","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/450695","article-title":"MGL receptor and immunity: when the ligand can make the difference","volume":"2015","author":"Zizzari","year":"2015","journal-title":"J. Immunol. Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.134899_bb0510","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1128\/JVI.02014-13","article-title":"The macrophage galactose-type lectin can function as an attachment and entry receptor for influenza virus","volume":"88","author":"Ng","year":"2014","journal-title":"J. Virol."},{"issue":"Suppl. 1","key":"10.1016\/j.ijbiomac.2024.134899_bb0515","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000506898","article-title":"TNF-alpha blockers in inflammatory bowel diseases: practical recommendations and a user\u2019s guide: an update","volume":"101","author":"Vulliemoz","year":"2020","journal-title":"Digestion"},{"issue":"7242","key":"10.1016\/j.ijbiomac.2024.134899_bb0520","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/nature07774","article-title":"Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation","volume":"458","author":"Aouadi","year":"2009","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.ijbiomac.2024.134899_bb0525","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1016\/j.biomaterials.2013.01.079","article-title":"Galactosylated trimethyl chitosan-cysteine nanoparticles loaded with Map4k4 siRNA for targeting activated macrophages","volume":"34","author":"Zhang","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0530","first-page":"191","article-title":"The normal structure and function of CD44 and its role in neoplasia","volume":"51","author":"Sneath","year":"1998","journal-title":"J. Clin. Pathol.: Mol. Pathol."},{"issue":"Pt A","key":"10.1016\/j.ijbiomac.2024.134899_bb0535","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.biocel.2016.09.009","article-title":"CD44: more than a mere stem cell marker","volume":"81","author":"Morath","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"32","key":"10.1016\/j.ijbiomac.2024.134899_bb0540","doi-asserted-by":"crossref","first-page":"52553","DOI":"10.18632\/oncotarget.9651","article-title":"Targeting folate receptor alpha for cancer treatment","volume":"7","author":"Cheung","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.134899_bb0545","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13075-019-1912-0","article-title":"Depletion of activated macrophages with a folate receptor-beta-specific antibody improves symptoms in mouse models of rheumatoid arthritis","volume":"21","author":"Hu","year":"2019","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.134899_bb0550","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/ecco-jcc\/jjx115","article-title":"Oral delivery of nanoparticles loaded with ginger active compound, 6-shogaol, attenuates ulcerative colitis and promotes wound healing in a murine model of ulcerative colitis","volume":"12","author":"Zhang","year":"2018","journal-title":"J. Crohns Colitis"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.134899_bb0555","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1016\/j.fct.2011.08.012","article-title":"Anti-inflammatory effects of [6]-shogaol: potential roles of HDAC inhibition and HSP70 induction","volume":"49","author":"Shim","year":"2011","journal-title":"Food Chem. Toxicol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.134899_bb0560","doi-asserted-by":"crossref","DOI":"10.3390\/nu9040382","article-title":"Associations between folate and vitamin B12 levels and inflammatory bowel disease: a meta-analysis","volume":"9","author":"Pan","year":"2017","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.134899_bb0565","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1053\/gast.2001.24845","article-title":"Colonic epithelial hPepT1 expression occurs in inflammatory bowel disease: transport of bacterial peptides influences expression of MHC class 1 molecules","volume":"120","author":"Merlin","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0570","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bcp.2017.12.025","article-title":"Expression and regulation of proton-coupled oligopeptide transporters in colonic tissue and immune cells of mice","volume":"148","author":"Wang","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"15","key":"10.1016\/j.ijbiomac.2024.134899_bb0575","doi-asserted-by":"crossref","first-page":"13029","DOI":"10.1021\/acsami.7b00936","article-title":"Peptide receptor-targeted fluorescent probe: visualization and discrimination between chronic and acute ulcerative colitis","volume":"9","author":"Zeng","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijbiomac.2024.134899_bb0580","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.bcp.2019.03.022","article-title":"Modulation of innate immunity by cyclosporine A","volume":"163","author":"Liddicoat","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.134899_bb0585","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1039\/C9BM00925F","article-title":"A PepT1 mediated medicinal nano-system for targeted delivery of cyclosporine A to alleviate acute severe ulcerative colitis","volume":"7","author":"Wu","year":"2019","journal-title":"Biomater. Sci."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024057040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024057040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T21:07:53Z","timestamp":1782767273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024057040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":117,"alternative-id":["S0141813024057040"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.134899","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of chitosan as nano carrier in the treatment of inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.134899","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"134899"}}